Effect of Oral Isotretinoin Treatment on Retinal Nerve Fiber Layer Thickness

dc.contributor.authorUcak, Haydar
dc.contributor.authorAykut, Veysel
dc.contributor.authorOzturk, Savas
dc.contributor.authorCicek, Demet
dc.contributor.authorErden, Ilker
dc.contributor.authorDemir, Betul
dc.date.accessioned2026-08-12T17:48:19Z
dc.date.issued2014
dc.departmentFırat Üniversitesi
dc.description.abstractBackground: Oral isotretinoin treatment can cause ocular side effects. Objective: This study was performed to detect possible toxic effects of oral isotretinoin treatment on the retinal nerve fiber layer (RNFL) and ganglion cell layer (GCL). Methods: The study population consisted of 54 eyes of 27 patients with nodulocystic acne who used oral isotretinoin (Roaccutane) treatment. Macular GCL and peripapillary RNFL thickness measurements were performed using spectral domain optical coherence tomography (OCT) before and after therapy. Results: Before and after treatment, a complete ophthalmologic examination was normal in all eyes. However, posttreatment lower temporal (TL) values were significantly lower (76.80 +/- 16.31) than pretreatment TL values (84.96 +/- 24.83) (p = .02). There was no statistically significant difference in the other OCT values, upper temporal, superotemporal, superonasal, upper nasal, lower nasal, inferonasal, and inferotemporal (p = .35, p = .40, p = .56, p = .95, p = .94, p = .93, p = .61, respectively). Also, there was no statistically significant difference between the right and left eyes and between genders for all parameters (p > .05). Conclusion: The use of oral isotretinoin treatment has increased in recent years. In addition, oral isotretinoin treatment has a broad adverse effect potential on the ocular system. The measurement of RNFL thickness, especially TL thickness, by OCT may be useful for detecting the possible toxic effect of oral isotretinoin therapy on RNFL.
dc.identifier.doi10.2310/7750.2013.13168
dc.identifier.endpage242
dc.identifier.issn1203-4754
dc.identifier.issue4
dc.identifier.orcid0000-0002-6190-5124
dc.identifier.pmid25008440
dc.identifier.scopus2-s2.0-84904396903
dc.identifier.scopusqualityQ1
dc.identifier.startpage236
dc.identifier.urihttps://doi.org/10.2310/7750.2013.13168
dc.identifier.urihttps://hdl.handle.net/11508/61360
dc.identifier.volume18
dc.identifier.wosWOS:000344132000006
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherB C Decker Inc
dc.relation.ispartofJournal of Cutaneous Medicine and Surgery
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectOptical Coherence Tomography
dc.subjectAdverse Ocular Reactions
dc.subjectAcitretin Therapy
dc.subjectNeuropathy
dc.subjectAcid
dc.subjectChloroquine
dc.subjectRetinoids
dc.subjectGlaucoma
dc.subjectEyes
dc.titleEffect of Oral Isotretinoin Treatment on Retinal Nerve Fiber Layer Thickness
dc.typeArticle

Dosyalar